Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP480326.RAYGqYM_vl9av7JxpZm5PV_eWSm41dALHXSbm-Qr7Fx88130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP480326.RAYGqYM_vl9av7JxpZm5PV_eWSm41dALHXSbm-Qr7Fx88130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP480326.RAYGqYM_vl9av7JxpZm5PV_eWSm41dALHXSbm-Qr7Fx88130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP480326.RAYGqYM_vl9av7JxpZm5PV_eWSm41dALHXSbm-Qr7Fx88130_provenance.
- NP480326.RAYGqYM_vl9av7JxpZm5PV_eWSm41dALHXSbm-Qr7Fx88130_assertion description "[After stratification by disease stage or histologic subtype, the prognostic significance of high total COX-2 mRNA expression was still apparent in both stage I and stage II-IV and in both squamous cell carcinoma and adenocarcinoma (p < or = 0.01 for all).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480326.RAYGqYM_vl9av7JxpZm5PV_eWSm41dALHXSbm-Qr7Fx88130_provenance.
- NP480326.RAYGqYM_vl9av7JxpZm5PV_eWSm41dALHXSbm-Qr7Fx88130_assertion evidence source_evidence_literature NP480326.RAYGqYM_vl9av7JxpZm5PV_eWSm41dALHXSbm-Qr7Fx88130_provenance.
- NP480326.RAYGqYM_vl9av7JxpZm5PV_eWSm41dALHXSbm-Qr7Fx88130_assertion SIO_000772 15704107 NP480326.RAYGqYM_vl9av7JxpZm5PV_eWSm41dALHXSbm-Qr7Fx88130_provenance.
- NP480326.RAYGqYM_vl9av7JxpZm5PV_eWSm41dALHXSbm-Qr7Fx88130_assertion wasDerivedFrom befree-2016 NP480326.RAYGqYM_vl9av7JxpZm5PV_eWSm41dALHXSbm-Qr7Fx88130_provenance.
- NP480326.RAYGqYM_vl9av7JxpZm5PV_eWSm41dALHXSbm-Qr7Fx88130_assertion wasGeneratedBy ECO_0000203 NP480326.RAYGqYM_vl9av7JxpZm5PV_eWSm41dALHXSbm-Qr7Fx88130_provenance.
- befree-2016 importedOn "2016-02-19" NP480326.RAYGqYM_vl9av7JxpZm5PV_eWSm41dALHXSbm-Qr7Fx88130_provenance.